INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients With Remotely Monitored Implanted Cardioverter Defibrillators (ICD) SysTems

NCT ID: NCT01200381

Last Updated: 2019-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

210 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-02-28

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It's the aim of this study to analyze the benefit of personal patient / physician contacts in heart failure patients with remotely monitored implanted cardioverter defibrillators (ICD) or ICD with cardiac resynchronization therapy (CRT-D).

The personal follow up (in clinic or phone calls) will be compared to completely automatic remote follow ups.

All patients will receive remote monitoring for automatic daily alarm checks and will undergo in clinic follow ups in 12 months intervals

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Automatic anonymous ICD/CRTD follow up (quarterly remote follow ups)

Group Type ACTIVE_COMPARATOR

Quarterly remote follow ups and remote monitoring

Intervention Type OTHER

Quarterly remote follow ups and remote monitoring

Group B1

Personal ICD/CRTD follow up (phone calls + quarterly remote follow ups)

Group Type ACTIVE_COMPARATOR

Quarterly remote follow ups + additional phone calls and remote monitoring

Intervention Type OTHER

Quarterly remote follow ups + additional phone calls and remote monitoring

Group B2

Personal ICD/CRTD follow up (Quarterly visits)

Group Type ACTIVE_COMPARATOR

Quarterly in clinic follow ups and remote monitoring

Intervention Type OTHER

Quarterly in clinic follow ups and remote monitoring

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Quarterly remote follow ups and remote monitoring

Quarterly remote follow ups and remote monitoring

Intervention Type OTHER

Quarterly remote follow ups + additional phone calls and remote monitoring

Quarterly remote follow ups + additional phone calls and remote monitoring

Intervention Type OTHER

Quarterly in clinic follow ups and remote monitoring

Quarterly in clinic follow ups and remote monitoring

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Indication for implantation (new, boxchange, upgrade) of ICD/ CRT-D
* Written informed consent
* Ejection Fraction \<= 35%
* New York Heart Association (NYHA) Class I-III
* Age \>=18 and \<=80 years
* In patient's home environment sufficient infrastructure (analog phone line or sufficient strength of GSM (Global System for Mobile communication) mobile phone network) for running a Merlin@home transmitter is available

Exclusion Criteria

* Arterio ventricular (AV) Block III / AV Block II Type Mobitz
* Severe renal insufficiency
* Coronary angiology intervention within previous 3 months
* Myocardial infarction within previous month
* Life expectancy \< 1 year
* Expected poor data quality / compliance
* Pregnancy
* Patient is already participating to another study with active therapy arm
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Medical Devices

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian Weiss, Prof. Dr. med.

Role: STUDY_CHAIR

Städtisches Klinikum Lüneburg gGmbH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald

Bad Friedrichshall, , Germany

Site Status

Asklepios Klinik Bad Oldesloe

Bad Oldesloe, , Germany

Site Status

Segeberger Kliniken GmbH

Bad Segeberg, , Germany

Site Status

Evangelisches Krankenhaus Bielefeld gGmbH

Bielefeld, , Germany

Site Status

Evangelisches Krankenhaus Kalk

Cologne, , Germany

Site Status

Universitätsklinikum Essen (AöR)

Essen, , Germany

Site Status

Herzkatheterlabor der Kardiologischen Praxis am Krankenhaus Neu-Bethlehem gGmbH

Göttingen, , Germany

Site Status

Asklepios Klinik St. Georg

Hamburg, , Germany

Site Status

Asklepios Klinik Barmbek

Hamburg, , Germany

Site Status

Klinikum Ingolstadt GmbH

Ingolstadt, , Germany

Site Status

Kardiologische Praxis - Partnergesellschaft

Ludwigsburg, , Germany

Site Status

Städtisches Klinikum Lüneburg gGmbH

Lüneburg, , Germany

Site Status

Marienhaus Klinikum St. Elisabeth-Krankenhaus

Neuwied, , Germany

Site Status

Praxis Dr. med. Balbach / Ruppert

Nürtingen, , Germany

Site Status

Kardiologische Gemeinschaftspraxis am Park Sanssouci

Potsdam, , Germany

Site Status

Klinikum Sindelfingen-Böblingen gGmbH

Sindelfingen, , Germany

Site Status

Marienhospital Stuttgart

Stuttgart, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Hansen C, Loges C, Seidl K, Eberhardt F, Troster H, Petrov K, Gronefeld G, Bramlage P, Birkenhauer F, Weiss C. INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact). BMC Cardiovasc Disord. 2018 Jun 28;18(1):131. doi: 10.1186/s12872-018-0864-7.

Reference Type DERIVED
PMID: 29954340 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

T94

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Assessment of Combined CCM and ICD Device in HFrEF
NCT05855135 ACTIVE_NOT_RECRUITING NA